Proteins with expression significantly altered in the serum of Paracoccidioidomycosis patients with Severe and Mild/moderate pulmonary sequel (PS) as outcome in the moment of apparent cure.</p
Comparison of serum proteins, presented as mean and standard deviation in patients with paracoccidio...
Paracoccidioidomycosis (PCM) is a systemic disease caused by thermodymorphic fungi of the Paracoccid...
Quantification of serum proteins by spectral counting, presented as mean and standard deviation in p...
Proteins with expression significantly altered in the serum of paracoccidioidomycosis patients with ...
Proteins with expression significantly altered in the serum of paracoccidioidomycosis patients with ...
Proteins with expression significantly altered in the serum of paracoccidioidomycosis patients with ...
(A) Number of proteins down- or upregulated in PCM patients with severe PS compared to patients with...
(A) Number of proteins down- or upregulated in PCM patients with severe PS compared to patients with...
NanoACQUITY UPLC-Xevo QT MS system and PLGS Expression E software were used to identify differential...
(A) Number of proteins down- or upregulated in PCM patients with severe PS compared to patients with...
Qualitative analysis of serum proteins in the group of paracoccidioidomycosis patients (Group G2) be...
Qualitative analysis of serum proteins in the group of paracoccidioidomycosis patients with relapse ...
Qualitative analysis of serum proteins of patients with paracoccidioidomycosis—G1 and G2 groups and ...
Qualitative analysis of serum proteins of patients with paracoccidioidomycosis, evaluated before tre...
Serum concentrations of MIP-1α and VEGF in chronic PCM patients with mild/moderate or severe pulmona...
Comparison of serum proteins, presented as mean and standard deviation in patients with paracoccidio...
Paracoccidioidomycosis (PCM) is a systemic disease caused by thermodymorphic fungi of the Paracoccid...
Quantification of serum proteins by spectral counting, presented as mean and standard deviation in p...
Proteins with expression significantly altered in the serum of paracoccidioidomycosis patients with ...
Proteins with expression significantly altered in the serum of paracoccidioidomycosis patients with ...
Proteins with expression significantly altered in the serum of paracoccidioidomycosis patients with ...
(A) Number of proteins down- or upregulated in PCM patients with severe PS compared to patients with...
(A) Number of proteins down- or upregulated in PCM patients with severe PS compared to patients with...
NanoACQUITY UPLC-Xevo QT MS system and PLGS Expression E software were used to identify differential...
(A) Number of proteins down- or upregulated in PCM patients with severe PS compared to patients with...
Qualitative analysis of serum proteins in the group of paracoccidioidomycosis patients (Group G2) be...
Qualitative analysis of serum proteins in the group of paracoccidioidomycosis patients with relapse ...
Qualitative analysis of serum proteins of patients with paracoccidioidomycosis—G1 and G2 groups and ...
Qualitative analysis of serum proteins of patients with paracoccidioidomycosis, evaluated before tre...
Serum concentrations of MIP-1α and VEGF in chronic PCM patients with mild/moderate or severe pulmona...
Comparison of serum proteins, presented as mean and standard deviation in patients with paracoccidio...
Paracoccidioidomycosis (PCM) is a systemic disease caused by thermodymorphic fungi of the Paracoccid...
Quantification of serum proteins by spectral counting, presented as mean and standard deviation in p...